CLARIANE SE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.88 EUR | +18.69% |
|
+18.54% | -21.80% |
| 04-26 | CLARIANE : Reiterated outlook backed by a buoyant Q1 |  |
| 04-26 | Transcript : Clariane SE, Q1 2024 Sales/ Trading Statement Call, Apr 26, 2024 |
Chart calendar Clariane SE
89527fbc2a6f1532cd6223acec3.2qdg7AdUoYx0pwiMW8AptL5pwR2WMSASxdNAh_ea3bc.qt8lg309xsgawz_aCJ9R88xQg1HsBm1Gkbgy6ofbh_ie4QahZT6QxgyUWQ~bab9fc7375b412d6ecca0816c8eb1e8f
Upcoming events on Clariane SE
Past events on Clariane SE
| 2024-04-26 09:00 | Q1 2024 Sales and Revenue Call |
| 2024-04-25 12:20 | Q1 2024 Sales and Revenue Release |
| 2024-03-26 09:00 | Extraordinary Shareholders Meeting |
| 2024-02-29 09:00 | Q4 2023 Earnings Call |
| 2024-02-28 12:41 | Q4 2023 Earnings Release |
| 2023-11-14 03:00 | Business Update Call |
| 2023-10-25 09:00 | Q3 2023 Sales and Revenue Call |
| 2023-10-24 12:00 | Q3 2023 Sales and Revenue Release |
| 2023-07-27 12:45 | Q2 2023 Earnings Call |
| 2023-07-27 12:00 | Q2 2023 Earnings Release |
| 2023-06-20 | Ex-dividend day for final dividend (optional) |
| 2023-06-15 08:00 | Annual General Meeting |
| 2023-04-26 03:00 | Investor Meeting |
| 2023-04-25 12:00 | Q1 2023 Sales and Revenue Call |
| 2023-04-25 11:40 | Q1 2023 Sales and Revenue Release |
| 2023-02-22 03:00 | FY 2022 Earnings Call |
| 2023-02-21 12:21 | FY 2022 Earnings Release |
| 2022-12-04 | Berenberg European Conference |
| 2022-10-27 12:30 | Q3 2022 Sales and Revenue Call |
| 2022-10-27 11:45 | Q3 2022 Sales and Revenue Release |
Past dividends on Clariane SE
| 2023-06-20 | Annual 0.25 EUR |
| 2022-06-27 | Annual 0.35 EUR |
| 2021-06-03 | Annual 0.3 EUR |
| 2019-06-10 | Annual 0.6 EUR |
| 2018-06-20 | Annual 0.6 EUR |
| 2017-06-27 | Annual 0.6 EUR |
| 2016-06-28 | Annual 0.6 EUR |
| 2015-06-30 | Annual 0.6 EUR |
| 2014-07-02 | Annual 0.6 EUR |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 3 613 3 611 0.05% | 3 874 3 813 1.59% | 4 311 4 285 0.6% | 4 534 4 579 -0.97% | 5 048 4 993 1.09% | 5 293 |
|
EBITDA Million EUR | Released Forecast Spread | 885 889 -0.46% | 861 846 1.8% | 1 010 998 1.22% | 1 003 1 055 -4.94% | 1 021 1 006 1.56% | 1 026 |
|
EBIT Million EUR | Released Forecast Spread | 374 397 -5.72% | 304 297 2.65% | 342 395 -13.47% | 348 391 -10.89% | 328 303 8.31% | 327 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 176 200 -12.25% | 60,0 86,4 -30.52% | 132 168 -21.4% | 57,9 126 -54.05% | -76,2 41,3 -284.3% | -37,0 |
|
Net income Million EUR | Released Forecast Spread | 115 131 -12.71% | 39,4 53,0 -25.62% | 94,6 109 -12.99% | 22,1 80,4 -72.52% | -105 19,5 -639.93% | -25,6 |
|
EPS EUR | Released Forecast Spread | 1,29 1,60 -19.38% | 0,30 0,58 -48.48% | 0,73 1,07 -31.62% | 0,13 0,87 -85.12% | -0,99 0,21 -571.43% | 0,42 |
| Announcement Date | 27/02/20 | 24/02/21 | 23/02/22 | 21/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2021 S1 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 1 845 1 831 0.78% | 1 877 1 860 0.87% | 2 108 2 053 2.65% | 1 121 1 127 -0.53% | 1 094 1 105 -1% | 1 130 1 148 -1.53% | 2 224 2 241 -0.78% | 1 135 1 141 -0.54% | 1 190 1 241 -4.11% | 1 267 1 251 1.23% | 2 485 2 469 0.62% | 1 246 1 261 -1.12% | 1 316 1 273 3.37% | 1 308 1 284 1.87% | |||
|
EBITDA Million EUR | Released Forecast Spread | 407 408 -0.17% | 491 492 -0.25% | 482 501 -3.79% | ||||||||||||||
|
EBIT Million EUR | Released Forecast Spread | 212 | 141 121 16.53% | 166 176 -5.57% | 176 209 -16.09% | 169 152 11.37% | 179 183 -2.18% | 145 176 -17.85% | 184 158 16.42% | |||||||||
|
Net income Million EUR | Released Forecast Spread | 54,6 | ||||||||||||||||
| Announcement Date | 27/02/20 | 30/07/20 | 29/07/21 | 23/02/22 | 23/02/22 | 25/04/22 | 28/07/22 | 28/07/22 | 27/10/22 | 21/02/23 | 21/02/23 | 27/07/23 | 27/07/23 | 24/10/23 | 28/02/24 | 28/02/24 | - |
More events
Past sector events for Clariane SE
| 2024-04-26 07:30 | HCA HEALTHCARE, INC.: Q1 2024 Earnings Release |
| 2024-04-26 07:28 | PT MEDIKALOKA HERMINA TBK: Q1 2024 Earnings Release |
| 2024-04-26 01:45 | MEDICOVER AB: Q1 2024 Earnings Release |
| 2024-04-25 | NEW JOURNEY HEALTH TECHNOLOGY GROUP CO.,LTD: Q1 2024 Earnings Release |
| 2024-04-25 16:03 | ACCOLADE, INC.: Q4 2024 Earnings Release |
| 2024-04-25 06:58 | LABORATORY CORPORATION OF AMERICA HOLDINGS: Q1 2024 Earnings Release |
| 2024-04-24 21:09 | BUMRUNGRAD HOSPITAL: Q1 2024 Earnings Release |
| 2024-04-24 | MEINIAN ONEHEALTH HEALTHCARE HOLDINGS CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-24 16:16 | UNIVERSAL HEALTH SERVICES, INC.: Q1 2024 Earnings Release |
| 2024-04-24 16:15 | CHEMED CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CLARI Stock
- Calendar Clariane SE
